Appia Signs Definitive Agreement to Acquire up to a 70% Interest in Ionic Clay Project, Brazil

pharmaceutical Investing News

Download our investor reports
Start Here GuidesOutlook Reports
Copyright 2023 © Dig Media Inc.

Your trusted source for investing success since 2007. Renowned for our market outlook reports and investing guides.
Pharmaceutical Investing

Pharma Market Forecast: 3 Top Trends That Will Affect Pharma in 2023

Pharma stocks retreated in 2022 as the market faced challenges. Will the sector become a safe haven for investors again in 2023?

Latest Articles
Pharmaceutical Investing

Top 10 Pharma Companies by Revenue (Updated 2023)

Biotech Investing

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies in 2023

Pharmaceutical Investing

What is In-Licensing? (Updated 2023)

Company Profiles
CRDL:CA

Cardiol Therapeutics

Heal the heart with innovative science.

BCT:CA

BriaCell

Developing Personalized Off-The-Shelf Immunotherapy Treatments for Cancer Patients

ABRT:CNX

Albert Labs

Innovative medicines for patients with urgent and unmet needs

CEO Interviews
Pharmaceutical Investing

Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says

Psychedelics Investing

Albert Labs Eyes One Dose Psilocybin Treatment for Cancer-related Anxiety

Medical Device Investing

Avricore Health CEO Touts Pharmacists' Role in Patient Care

Trending
Pharmaceutical Investing

Top 3 Canadian Pharma Stocks of 2023

Pharmaceutical Investing

Pharma Stocks: 5 Biggest Companies in 2023

Pharmaceutical Investing

Why Consider Investing in Pharmaceutical Stocks? (Updated 2023)

Press Releases
Life Science Investing

Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees

Editors' Picks
Don't Miss
Pharmaceutical Investing

KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA

Life Science Investing

LUPKYNIS® Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone

Medical Device Investing

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

Life Science Investing

Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees

Medical Device Investing

New Clinical Study Suggests the Use of OraPharma's ARESTIN Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis

Medical Device Investing

U.S. District Court Upholds Final Judgment for XIFAXAN 550 mg That Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029

Life Science Investing

Aurinia Announces 2023 Annual General Meeting Results

MARKETS

Markets
TSX19892.06-50.64
TSXV610.32-1.36
DOW33876.78+43.17
S&P 5004298.86+4.93
NASD13259.14+20.62
ASX7099.70-18.30

COMMODITIES

Commodities
Gold1960.87-4.46
Silver24.28+0.02
Copper3.77-0.02
Palladium1713.170.00
Platinum1087.260.00
Oil70.36-0.93
Heating Oil2.36-0.03
Natural Gas2.26-0.09

DOWNLOAD FREE REPORTS

BROWSE COMPANIES BY SECTOR

×